- Home
- Publications
- Publication Search
- Publication Details
Title
Ruthenium Complexes as Promising Candidates against Lung Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 15, Pages 4389
Publisher
MDPI AG
Online
2021-07-21
DOI
10.3390/molecules26154389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Half sandwiched RutheniumII complexes: En Route towards the targeted delivery by Human Serum Albumin (HSA)
- (2021) Suboot Hairat et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway
- (2021) Yu Lu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Lung Cancer 2020
- (2020) Brett C. Bade et al. CLINICS IN CHEST MEDICINE
- Design, Synthesis, and Biological Evaluation of Proteolysis Targeting Chimeras (PROTACs) for the Dual Degradation of IGF-1R and Src
- (2020) Sudhakar Manda et al. MOLECULES
- Synthesis and Structure of Arene Ru(II) N∧O-Chelating Complexes: In Vitro Cytotoxicity and Cancer Cell Death Mechanism
- (2020) Sundarraman Balaji et al. ORGANOMETALLICS
- Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II
- (2020) Kai Xiong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ru(II) Complexes Bearing O, O-Chelated Ligands Induced Apoptosis in A549 Cells through the Mitochondrial Apoptotic Pathway
- (2020) Jincan Chen et al. BIOINORGANIC CHEMISTRY AND APPLICATIONS
- Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity
- (2020) Mônica Soares Costa et al. Scientific Reports
- The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells
- (2020) Christelle Fayad et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
- (2020) Sang Yeul Lee et al. Drug Design Development and Therapy
- Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η6-p-cymene) complex in human non-small cell lung cancer via p53-dependent pathway
- (2019) Muhammad Zeeshan Bhatti et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Novel insights into cell cycle regulation of cell fate determination
- (2019) Su-wei Gao et al. Journal of Zhejiang University-SCIENCE B
- The role of necroptosis in cancer biology and therapy
- (2019) Yitao Gong et al. Molecular Cancer
- NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
- (2019) Enzo Alessio et al. MOLECULES
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes
- (2019) Manzoor Ahmad Malik et al. BIOORGANIC CHEMISTRY
- Autophagy as a molecular target for cancer treatment
- (2019) Nur Mehpare Kocaturk et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Increased ROS generation causes apoptosis-like death: Mechanistic insights into the anti-Leishmania activity of a potent ruthenium(II) complex
- (2019) Mônica Soares Costa et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Iridium(III) Complexes Targeting Apoptotic Cell Death in Cancer Cells
- (2019) Dik-Lung Ma et al. MOLECULES
- Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
- (2019) Marialuisa Piccolo et al. Scientific Reports
- Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
- (2019) Ana Rilak Simović et al. COORDINATION CHEMISTRY REVIEWS
- Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo
- (2019) Mohamed Kasim Mohamed Subarkhan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis
- (2019) Melanie Fritsch et al. NATURE
- Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation
- (2019) Mara Bonelli et al. BIOCHEMICAL PHARMACOLOGY
- FasL on the surface of Tag7 (PGRP-S)-activated lymphocytes induces necroptosis in HLA-negative tumor cells with the involvement of lysosomes and mitochondria
- (2018) Tatiana N. Sharapova et al. BIOCHIMIE
- Targeting autophagy in cancer
- (2018) Angelique V. Onorati et al. CANCER
- Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy
- (2018) Christopher C. Mills et al. CANCER RESEARCH
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
- (2018) Sreekanth Thota et al. JOURNAL OF MEDICINAL CHEMISTRY
- “Chemistry-on-the-complex”: functional RuII polypyridyl-type sensitizers as divergent building blocks
- (2018) Tina Mede et al. CHEMICAL SOCIETY REVIEWS
- Rhodium at the chemistry–biology interface
- (2018) Jun Ohata et al. DALTON TRANSACTIONS
- Rigid dinuclear ruthenium-arene complexes showing strong DNA interactions
- (2018) Qi Wu et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
- (2018) Ke Lin et al. Frontiers in Pharmacology
- ROS and the DNA damage response in cancer
- (2018) Upadhyayula Sai Srinivas et al. Redox Biology
- Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O′-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells
- (2018) Maddalena Grimaldi et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes
- (2017) Orsolya Dömötör et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: Playing with auxiliary ligands for tuning the mechanism of biological activity
- (2017) Michał Łomzik et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Anti- Leishmania activity of new ruthenium(II) complexes: Effect on parasite-host interaction
- (2017) Mônica S. Costa et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review
- (2017) Jurgen Peerlings et al. METHODS
- [Ru(pipe)(dppb)(bipy)]PF 6 : A novel ruthenium complex that effectively inhibits ERK activation and cyclin D1 expression in A549 cells
- (2017) Guilherme A. Ferreira-Silva et al. TOXICOLOGY IN VITRO
- Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamine
- (2017) Jiao-Lan Qin et al. Oncotarget
- Adipocyte-derived exosomes promote lung cancer metastasis by increasing MMP9 activity via transferring MMP3 to lung cancer cells
- (2017) Jiaoli Wang et al. Oncotarget
- The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells
- (2017) Jun Yang et al. Oncotarget
- Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
- (2017) Carlo Irace et al. Scientific Reports
- “Dressing up” an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents
- (2017) Claudia Riccardi et al. ACS Biomaterials-Science & Engineering
- “Dressing up” an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents
- (2017) Claudia Riccardi et al. ACS Biomaterials Science & Engineering
- Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
- (2016) Giuseppa Pistritto et al. Aging-US
- Solvent assisted formation of ruthenium(iii) and ruthenium(ii) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release
- (2016) Eswaran Jayanthi et al. DALTON TRANSACTIONS
- Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
- (2016) Enzo Alessio EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- RuIIIComplexes for Anticancer Therapy: The Importance of Being Nucleolipidic
- (2016) Claudia Riccardi et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
- (2016) Antonio Rossi et al. Expert Review of Anticancer Therapy
- The studies on the cytotoxicity in vitro, cellular uptake, cell cycle arrest and apoptosis-inducing properties of ruthenium methylimidazole complex [Ru(MeIm)4(p-cpip)]2+
- (2016) Lan-mei Chen et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex
- (2016) Lanmei Chen et al. Oncotarget
- Antimetastatic activity of novel ruthenium (III) pyridine complexes
- (2016) Liwei Gu et al. Cancer Medicine
- Lightening up Ruthenium Complexes to Fight Cancer?
- (2015) Cristina Mari et al. CHIMIA
- Cytotoxic activity, DNA damage, cellular uptake, apoptosis and western blot analysis of ruthenium(II) polypyridyl complex against human lung decarcinoma A549 cell
- (2015) Shang-Hai Lai et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Necroptosis-Inducing Rhenium(V) Oxo Complexes
- (2015) Kogularamanan Suntharalingam et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells
- (2015) Olga Mazuryk et al. Metallomics
- Dual inhibition of topoisomerases I and IIα by ruthenium(ii) complexes containing asymmetric tridentate ligands
- (2014) Kejie Du et al. DALTON TRANSACTIONS
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- 2-Nitroimidazole-ruthenium polypyridyl complex as a new conjugate for cancer treatment and visualization
- (2014) Olga Mazuryk et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Bioactive Luminescent Transition-Metal Complexes for Biomedical Applications
- (2013) Dik-Lung Ma et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ruthenium complexes in different oxidation states: synthesis, crystal structure, spectra and redox properties
- (2013) Agnieszka Jabłońska-Wawrzycka et al. DALTON TRANSACTIONS
- Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells
- (2013) Wei Guo et al. INORGANIC CHEMISTRY
- Targetting cancer with Ru(III/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancer
- (2013) Raj Kumar Koiri et al. MEDICAL HYPOTHESES
- Hetero-multinuclear Ruthenium(III)/Platinum(II) Complexes That Potentially Exhibit Both Antimetastatic and Antineoplastic Properties
- (2012) Craig M. Anderson et al. INORGANIC CHEMISTRY
- Ruthenium methylimidazole complexes induced apoptosis in lung cancer A549 cells through intrinsic mitochondrial pathway
- (2011) Xiaoxin Yang et al. BIOCHIMIE
- Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
- (2011) Michael I. Webb et al. INORGANIC CHEMISTRY
- Characterization of a Ruthenium(III)/NAMI-A Adduct with Bovine Serum Albumin that Exhibits a High Anti-Metastatic Activity
- (2010) Mimi Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- Dual anti-angiogenic and cytotoxic properties of ruthenium(iii) complexes containing pyrazolato and/or pyrazole ligands
- (2009) Raymond Wai-Yin Sun et al. DALTON TRANSACTIONS
- Areneruthenium complexes as anticancer agents
- (2009) Georg Süss-Fink DALTON TRANSACTIONS
- p53 represses c-Myc through induction of the tumor suppressor miR-145
- (2009) M. Sachdeva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- The ruthenium(II)–arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53–JNK pathways
- (2008) Soumya Chatterjee et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Caspase-independent cell death: leaving the set without the final cut
- (2008) S W G Tait et al. ONCOGENE
- Synthesis, Characterization, and in Vitro Evaluation of a Potentially Selective Anticancer, Mixed-Metal [Ruthenium(III)−Platinum(II)] Trinuclear Complex
- (2007) Amnon Herman et al. INORGANIC CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started